| Biological Information | |
|---|---|
| Background Information: | Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis; ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise. Provided as 0.5 mg of dry powder. |
| Target Name: | ANP |
| Usage | |
| Product Type: | Peptides |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at -20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
ANP(1-28)
ANP(1-28) is an agonist for NPR1. This product is provided as 0.5 mg of dry powder.
Datasheets
92-1337 Datasheet
View Document